181 related articles for article (PubMed ID: 15331590)
1. Resistance of the human beta1-adrenergic receptor to agonist-induced ubiquitination: a mechanism for impaired receptor degradation.
Liang W; Fishman PH
J Biol Chem; 2004 Nov; 279(45):46882-9. PubMed ID: 15331590
[TBL] [Abstract][Full Text] [Related]
2. Beta2-adrenergic receptor lysosomal trafficking is regulated by ubiquitination of lysyl residues in two distinct receptor domains.
Xiao K; Shenoy SK
J Biol Chem; 2011 Apr; 286(14):12785-95. PubMed ID: 21330366
[TBL] [Abstract][Full Text] [Related]
3. Low affinity of beta1-adrenergic receptor for beta-arrestins explains the resistance to agonist-induced internalization.
Shiina T; Nagao T; Kurose H
Life Sci; 2001 Apr; 68(19-20):2251-7. PubMed ID: 11358334
[TBL] [Abstract][Full Text] [Related]
4. Resistance of the human beta 1-adrenergic receptor to agonist-mediated down-regulation. Role of the C terminus in determining beta-subtype degradation.
Liang W; Austin S; Hoang Q; Fishman PH
J Biol Chem; 2003 Oct; 278(41):39773-81. PubMed ID: 12888573
[TBL] [Abstract][Full Text] [Related]
5. Trans-Golgi Network (TGN) as a regulatory node for β1-adrenergic receptor (β1AR) down-modulation and recycling.
Cheng SB; Filardo EJ
J Biol Chem; 2012 Apr; 287(17):14178-91. PubMed ID: 22378779
[TBL] [Abstract][Full Text] [Related]
6. Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin.
Shenoy SK; McDonald PH; Kohout TA; Lefkowitz RJ
Science; 2001 Nov; 294(5545):1307-13. PubMed ID: 11588219
[TBL] [Abstract][Full Text] [Related]
7. A primate-dominant third glycosylation site of the beta2-adrenergic receptor routes receptors to degradation during agonist regulation.
Mialet-Perez J; Green SA; Miller WE; Liggett SB
J Biol Chem; 2004 Sep; 279(37):38603-7. PubMed ID: 15247302
[TBL] [Abstract][Full Text] [Related]
8. Role of clathrin-mediated endocytosis in agonist-induced down-regulation of the beta2-adrenergic receptor.
Gagnon AW; Kallal L; Benovic JL
J Biol Chem; 1998 Mar; 273(12):6976-81. PubMed ID: 9507004
[TBL] [Abstract][Full Text] [Related]
9. Similarities and differences in the coupling of human beta1- and beta2-adrenoceptors to Gs(alpha) splice variants.
Wenzel-Seifert K; Liu HY; Seifert R
Biochem Pharmacol; 2002 Jul; 64(1):9-20. PubMed ID: 12106601
[TBL] [Abstract][Full Text] [Related]
10. The deubiquitinase ubiquitin-specific protease 20 is a positive modulator of myocardial β
Yu SM; Jean-Charles PY; Abraham DM; Kaur S; Gareri C; Mao L; Rockman HA; Shenoy SK
J Biol Chem; 2019 Feb; 294(7):2500-2518. PubMed ID: 30538132
[TBL] [Abstract][Full Text] [Related]
11. Trafficking, ubiquitination, and down-regulation of the human platelet-activating factor receptor.
Dupré DJ; Chen Z; Le Gouill C; Thériault C; Parent JL; Rola-Pleszczynski M; Stankova J
J Biol Chem; 2003 Nov; 278(48):48228-35. PubMed ID: 14500726
[TBL] [Abstract][Full Text] [Related]
12. Beta-adrenergic receptor subtypes that mediate ractopamine stimulation of lipolysis.
Mills SE; Spurlock ME; Smith DJ
J Anim Sci; 2003 Mar; 81(3):662-8. PubMed ID: 12661646
[TBL] [Abstract][Full Text] [Related]
13. Sustained activation of a G protein-coupled receptor via "anchored" agonist binding. Molecular localization of the salmeterol exosite within the 2-adrenergic receptor.
Green SA; Spasoff AP; Coleman RA; Johnson M; Liggett SB
J Biol Chem; 1996 Sep; 271(39):24029-35. PubMed ID: 8798639
[TBL] [Abstract][Full Text] [Related]
14. Receptor/beta-arrestin complex formation and the differential trafficking and resensitization of beta2-adrenergic and angiotensin II type 1A receptors.
Anborgh PH; Seachrist JL; Dale LB; Ferguson SS
Mol Endocrinol; 2000 Dec; 14(12):2040-53. PubMed ID: 11117533
[TBL] [Abstract][Full Text] [Related]
15. Role of mammalian vacuolar protein-sorting proteins in endocytic trafficking of a non-ubiquitinated G protein-coupled receptor to lysosomes.
Hislop JN; Marley A; Von Zastrow M
J Biol Chem; 2004 May; 279(21):22522-31. PubMed ID: 15024011
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of alveolar epithelial active Na+ transport is dependent on beta2-adrenergic receptor signaling.
Mutlu GM; Dumasius V; Burhop J; McShane PJ; Meng FJ; Welch L; Dumasius A; Mohebahmadi N; Thakuria G; Hardiman K; Matalon S; Hollenberg S; Factor P
Circ Res; 2004 Apr; 94(8):1091-100. PubMed ID: 15016730
[TBL] [Abstract][Full Text] [Related]
17. Domains of beta1 and beta2 adrenergic receptors to bind subtype selective agonists.
Kurose H; Isogaya M; Kikkawa H; Nagao T
Life Sci; 1998; 62(17-18):1513-7. PubMed ID: 9585128
[TBL] [Abstract][Full Text] [Related]
18. β
Yang HQ; Wang LP; Gong YY; Fan XX; Zhu SY; Wang XT; Wang YP; Li LL; Xing X; Liu XX; Ji GS; Hou T; Zhang Y; Xiao RP; Wang SQ
Circ Res; 2019 Apr; 124(9):1350-1359. PubMed ID: 30836825
[TBL] [Abstract][Full Text] [Related]
19. beta-Arrestin mediates beta1-adrenergic receptor-epidermal growth factor receptor interaction and downstream signaling.
Tilley DG; Kim IM; Patel PA; Violin JD; Rockman HA
J Biol Chem; 2009 Jul; 284(30):20375-86. PubMed ID: 19509284
[TBL] [Abstract][Full Text] [Related]
20. Non-classical regulation of β1- and β 2-adrenoceptor-mediated inotropic responses in rat heart ventricle by the G protein Gi.
Melsom CB; Hussain RI; Ørstavik Ø; Aronsen JM; Sjaastad I; Skomedal T; Osnes JB; Levy FO; Krobert KA
Naunyn Schmiedebergs Arch Pharmacol; 2014 Dec; 387(12):1177-86. PubMed ID: 25216690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
